BRIDGEWATER, N.J., Nov. 29, 2018 (GLOBE NEWSWIRE) — Nevakar Inc., a specialty pharmaceutical company developing multiple differentiated products in the ophthalmic and injectable areas, announced today that it has entered into a $20 million senior secured term loan with Oxford Finance LLC. As part of the financing agreement, Nevakar may also access an additional $10 →
SYDNEY, July 31, 2018 (Newswire.com) – Parnell Pharmaceuticals Holdings Ltd. (OTC PINK: PARNF) (“Parnell” or the “Company”), a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal and human health solutions, today announced it has entered into a credit agreement with affiliated entities of New York-headquartered Marathon Asset Management (“Marathon”). Parnell will use →
DURHAM, N.C.–(BUSINESS WIRE)–Jul. 23, 2018– Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retina diseases and other diseases of the eye, today announced that the $125 million of senior secured convertible notes held by affiliates (the “holders”) →
Cambridge, UK and Indianapolis, US – 2 July 2018: Acacia Pharma Group plc (“Acacia Pharma”, the “Company” or the “Group”), (EURONEXT: ACPH), a hospital pharmaceutical company focused on the development and commercialisation of new nausea & vomiting treatments for surgical and cancer patients, has secured a credit facility of up to $30 million with Hercules →
May 23, 2018 at 4:05 PM EDT — Non-dilutive financing extends cash reach to over two years — RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–May 23, 2018– TransEnterix, Inc. (NYSE American: TRXC) (the “Company”), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that →
Agreement Extends Cash Runway into 2019 SAN JOSE, Calif., May 11, 2018 (GLOBE NEWSWIRE) — Restoration Robotics, Inc. (NASDAQ:HAIR), a leader in robotic hair restoration, announced today that it has reached an agreement with Solar Capital Ltd. and the Life Sciences Group at Bridge Bank to secure a debt facility agreement for $20.0 million. The →
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tricida, Inc. announced today that it has entered into a $100 million venture debt facility with Hercules Capital, Inc. (NYSE: HTGC), a leader in customizing debt financing for companies in the life sciences and technology-related markets. “Hercules is pleased to enter into this financing partnership with Tricida at this important stage →
ST. HELIER, Jersey–(BUSINESS WIRE)– Novocure (NASDAQ: NVCR) announced today that it has entered into a $150 million term loan agreement with BioPharma Credit PLC (LSE: BPCR), an investment fund managed by Pharmakon Advisors, LP, with proceeds used to pay in full Novocure’s existing $100 million term loan debt and fund working capital. The agreement improves →
Financing will fund the commercial launch of Intuity Medical’s POGO® Automatic™ Blood Glucose Monitoring System, the first fully-integrated blood glucose monitor FREMONT, Calif., Jan. 8, 2018 /PRNewswire/ — Intuity Medical, Inc., a privately-held company developing innovative technologies for diabetes management, announced today that it has closed $42.5M in the initial tranche of a $70M total round →
~ MACRILEN is the First and Only FDA-Approved Oral Drug Indicated For the Diagnosis of Adult Growth Hormone Deficiency, a Rare Endocrine Disorder ~ ~ MACRILEN is Strongbridge’s Second Commercial Product; Expands the Company’s Rare Endocrine Disease Portfolio and Complements its Late-Stage Clinical Development Program for RECORLEV™ (levoketoconazole) in Endogenous Cushing’s Syndrome ~ ~ Strongbridge →